Pharma R&D & Clinical Services · Indirect
Monitoring · monthlyProcurement Category Intelligence
Bioequivalence Studies
Overview
Market size
$720
global, USD
CAGR
6.8%
base to forecast
Buyer power
-1.8
supplier-favoured
Suppliers
9
tracked players
Signals
12
4 high severity
Market outlook
2031$1000
What changed
Demand by region
North America demand40%
Europe demand25%
Asia Pacific demand20%
Middle East & Africa demand10%
Latin America demand5%
share of global demandtotal 100%
Cost drivers
Clinical trials and patient investigator fees45%
Reference and test drug supply logistics25%
Bioanalytical laboratory testing and assays15%
Regulatory compliance and document data auditing10%
Data management and biostatistics5%
share of delivered cost (analyst estimate)